تسجيل الدخول
أهلا بك أيها الضيف الكريم
النشرات الاخبارية
THE MEDICAL NEWS
Inovio Biomedical announces additional immunogenicity data from therapeutic cervical cancer vaccine trial Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.
UnitedHealth Group announces results of previously announced debt tender offers UnitedHealth Group today announced the final results for its previously announced modified ?Dutch Auction? cash tender offers for certain of its notes. The tender offers expired at 12:00 midnight, New York City time, on February 5, 2010. As of the expiration date, UnitedHealth Group received tenders for $474 million aggregate principal amount of its short-term notes and $586 million aggregate principal amount of its intermediate-term notes.
Anthera Pharmaceuticals reaches agreement with the FDA on SPA for VISTA-16 clinical study Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
AMRI announces fourth-quarter and full-year 2009 results AMRI today reported financial and operating results for the fourth quarter and full year ending December 31, 2009.
CVS Caremark reports fourth-quarter and fiscal 2009 results CVS Caremark Corporation today announced record revenues, operating profit, and income from continuing operations for the fourth quarter and fiscal year ended December 31, 2009.
RSS integration by RSSinclude
Reuters: Health News
For obese, vaccine needle size matters NEW YORK (Reuters Health) - Our ever-expanding waistlines may have outgrown the doctor's needle, researchers say, in what could be another casualty of the obesity epidemic.
Age of mother affects child's autism risk: study CHICAGO (Reuters) - Being an older mother significantly increases the risk of having a child with autism, but being an older father only increases the risk when the mother is under the age of 30, U.S. researchers said on Monday.
Even third-hand smoke carries carcinogens: study WASHINGTON (Reuters) - Old tobacco smoke does more than simply make a room smell stale -- it can leave cancer-causing toxins behind, U.S. researchers reported on Monday.
Few high-risk women in U.S. take breast cancer drug NEW YORK (Reuters Health) - Only a small number of U.S. women at high risk of breast cancer have chosen to use the drug tamoxifen to lower that risk, according to a study published Monday.
Being religious may not make you healthier after all A number of studies over the past two decades have shown that religious people tend to be healthier. But a new study suggests that when it comes to heart disease and clogged arteries, attending religious services or having spiritual experiences may not protect against heart attacks and strokes.
RSS integration by RSSinclude
the medical informations and contents of the site are for consumer education and should not be considered or used as a substitute for medical advice,diagnosis or treatmentnt ..S ee disclaimer and editorial policy
contents revised by doctor osama elhesewei , last updated at 08/08/2009
المعلومات و الاستشارات الطبيه بالموقع للثقافه الطبيه و لا تغنى عن استشاره الطبيب راجع شروط استخدام الموقع تحديد المسئوليه تمت مراجعه الصفحه بواسطه دكتور / أسامه الحصيوى
